Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anas Younes

Showing results (1-10 of 310) with videos related to

Pageof 31
Sort By:
Seminars in Oncology|February 24, 2005
New treatment strategies for aggressive lymphomaAnas Younes
Hematology/Oncology Clinics of North America|November 30, 2013
Brentuximab vedotin for the treatment of patients with Hodgkin lymphomaAnas Younes
Hematological Oncology|June 13, 2019
New drugs for new targets in lymphomaAnas Younes
Cancer Journal (Sudbury, Mass.)|June 5, 2020
Introduction by the Guest EditorAnas Younes
Hemasphere|January 25, 2020
The Cantera: An Epic Learning Ring Cycle for Young HaematologistsAnas Younes
Hematological Oncology|June 8, 2017
Clinical applications of genome studiesAnas Younes
Current Opinion in Oncology|October 12, 2011
CD30-targeted antibody therapyAnas Younes
Clinical Advances in Hematology & Oncology : H&O|March 9, 2012
Highlights in lymphoma from the 2011 American Society of Hematology (ASH) Annual MeetingAnas Younes
Clinical Advances in Hematology & Oncology : H&O|June 13, 2009
New investigational drugs for lymphomaAnas Younes
Autophagy|May 13, 2008
Therapeutic activity of mTOR inhibitors in mantle cell lymphoma: clues but no clear answersAnas Younes
Pageof 31

Showing results (1-10 of 310) with videos related to

Sort By:
Pageof 31
Seminars in Oncology|February 24, 2005
New treatment strategies for aggressive lymphomaAnas Younes
Hematology/Oncology Clinics of North America|November 30, 2013
Brentuximab vedotin for the treatment of patients with Hodgkin lymphomaAnas Younes
Hematological Oncology|June 13, 2019
New drugs for new targets in lymphomaAnas Younes
Cancer Journal (Sudbury, Mass.)|June 5, 2020
Introduction by the Guest EditorAnas Younes
Hemasphere|January 25, 2020
The Cantera: An Epic Learning Ring Cycle for Young HaematologistsAnas Younes
Hematological Oncology|June 8, 2017
Clinical applications of genome studiesAnas Younes
Current Opinion in Oncology|October 12, 2011
CD30-targeted antibody therapyAnas Younes
Clinical Advances in Hematology & Oncology : H&O|March 9, 2012
Highlights in lymphoma from the 2011 American Society of Hematology (ASH) Annual MeetingAnas Younes
Clinical Advances in Hematology & Oncology : H&O|June 13, 2009
New investigational drugs for lymphomaAnas Younes
Autophagy|May 13, 2008
Therapeutic activity of mTOR inhibitors in mantle cell lymphoma: clues but no clear answersAnas Younes
Pageof 31